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Abstract: Introduction: Intradural extramedullary (IDEM) spinal cord tumours 
account two thirds of all intraspinal tumours. The objective of this study was to 
determine short- and long-term outcomes of surgical patients with IDEM spinal cord 
tumours, and to see clinical features that could be helpful in management of patients 
with these lesions (operated by single senior surgeononly). Methods: A retrospective 
review of 201 operative IDEM spinal cord tumours cases between 1993 and 2014 was 
performed. Outcomes were scored at one month and at mean follow-up of 8.5 months 
postoperatively. In addition, patient demographics, tumour types and locations were also 
collected. Statistical analysis was conducted utilizing Chi-square and Student's t-tests. 
Results: There were 93 men and 108 women (mean age 48 yrs, range 5 -87 yrs). Men 
presented at a younger age than women (42 vs 51 yrs, P<0.02). 165 (82.08 %) patients 
presented with severe radiculopathy and myelopathy. The 36 (17.91 %) had symptoms 
of radiculo -pathy. Mean duration of symptoms prior to diagnosis was 11 months. 
Schwannomas (113 patients) had the longest mean duration of symptoms (14.9 months), 
followed by meningiomas (68 patients, 8.4 months), and ependymomas (20 patients, 2 
months). Hundred and eighty nine (94%) of patients demonstrated significant 
improvement at one-month and 186 (92%) at 6-month mean follow-up. Only 39/201 
(19.4%) patients had residual focal deficits on long term follow-up. Conclusions: Surgery 
for IDEM should be expected to produce significant and dramatic improvement in most 
of patients. Demographic, tumor-specific and anatomic considerations will be clinically 
useful while managing IDEM.  
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Introduction 
Spinal tumors account for only 
approximately 5-15% of the nervous system 
neoplasms (13, 18). Intradural extramedullary 
(IDEM) spinal cord tumours account for 
about 60% of the intraspinal tumors, (17) and 
include schwannomas (1, 6) (30%; incidence 
rate, 0.3-0.4 cases annually per 100,000 
people), meningiomas (6, 22) (25%; incidence 
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rate, 0.32 cases annually per 100,000 people), 
neurofibromas, teratomas, lipomas, and 
metastatic tumors. 
The primary aim of this study was to 
examine surgical outcomes of IDEM spinal 
cord tumours in a large retrospective cohort of 
patients operated by single surgeon. Secondary 
objectives includes examination of clinical 
data related  to demographics, symptoms, 
tumor location and type that could be helpful 
in clinical decision making while managing 
these tumours.  
Materials and methods 
In this retrospective study of 201 surgical 
patients who underwent surgery for IDEM 
spinal cord tumours between January 1993 
and November 2014 were included.  
Parameters recorded include patients 
demographics, symptoms (severity and 
duration), tumor characteristics (anatomic 
and pathologic), postoperative follow-up and 
surgical outcomes.  
Surgical intervention was indicated by a 
combination of presenting symptoms 
(radiculopathy and/or myelopathy) and 
radiographic findings of   MRI. The 
neuroimaging procedure of choice was 
contrast-enhanced MRI.   
 Surgical outcomes were scored at 1 month 
and then at the mean follow-up period. The 
mean follow-up was calculated from the 
interval between surgery and the last complete 
clinical examination in the patient chart (in 
this study, 8.5 months). Patient records were 
carefully reviewed and surgical outcomes were 
scored strictly according to the modified 
criteria of Odom, et al (Table 1) (16). 
TABLE I 
Excellent Complete relief of pain and other 
symptoms, return to full activity. 
Good Partial relief of pain and other symptoms, 
return to full activity. 
Fair Improvement with persistent limitation of 
activities. 
Poor No improvement or further deterioration. 
Descriptive statistics, Chi-square test and Student's t-
test were utilized for data analysis. Statistical 
significance was set at alpha = 0.05. 
Note: other symptoms - paresthesias, paresis, sensory 
loss 
Results 
In this study there were 93 men and 108 
women (mean age 48 yrs, range 5 -87 yrs). 
Overall men presented at a younger age than 
women (42 vs 51 yrs, P<0.02).  The age 
distribution was bimodal with a major peak 
around 41 yrs and a minor peak around 70 yrs. 
The second peak around age 70 represents 
predominantly because of older meningioma 
patients, whereas the peak around age 41 due 
to schwannoma and ependymoma patients.  
There were three primary tumor types: 
schwannomas (113/201), meningiomas 
(68/201), and myxopapillary ependymomas 
(20/201) (Table 2A). Schwannomas were 
noted to be more common in men, 
meningiomas more common in women, and 
ependymomas distributed equally among men 
and women (Table 2A). Patients with 
meningiomas tends to be older (57 yrs) than 
those patients with schwannomas (44 yrs) and 
ependymomas (40yrs, P<0.01) (Table 2B).  
Tumor locations varied between the three 
tumour  subtypes in a predictable fashion 
(Table 2C) schwannomas were distributed 
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fairly evenly among the three anatomic 
regions (cervical, thoracic, and lumbosacral), 
meningiomas common  in  cervical and 
thoracic regions  and ependymomas were 
commonly localized to the lumbar region. The 
ratio of Schwannomas to Meningiomas to 
Ependymomas was approximately 4:2:1 in this 
study (actual ratio 113:68:20).  
The mean duration of symptoms before 
diagnosis was 11 months. Schwannomas had a 
statistically longer duration of symptoms (14.9 
months) than meningiomas (8.4 months, 
P<0.05) for cervical and thoracic tumors. 
Ependymomas had shorter duration of 
symptoms (2.0 months) than schwannomas 
(10.8 months, P<0.05) for lumbosacral 
tumors. 
Results of one month follow up 
Excellent Good Fair Poor 
75 (37.3%) 114 (56.7%) 9 (4.5%) 3 (1.5%) 
 
Results of Six months follow up 
Excellent Good Fair Poor 
123 (61.2%) 66 (32.8%) 12 (6%)  
 
Three patients had multiple IDEM, all of 
which were schwannomas. Two of these 
patients were NF-II positive. Four patients had 
recurrence of their IDEM spinal cord tumours. 
Three of these were schwannomas and one 
was an ependymoma. Two patients with 
recurrent dumbbell-shaped schwannomas 
within the soft tissues of the neck underwent 
surgical treatment with acceptable results (one 
patient returned with new symptoms 5 years 
after initial tumor excision while another 
patient presented 15 years after the initial 
surgery). One patient with recurrent 
ependymoma at 4 years following initial 
surgery underwent a successful course of 
radiotherapy, and one patient with 
schwannoma underwent non-operative semi-
annual observation for a localized 
radiographic recurrence.  
While no metastases were noted during the 
8.5 month mean follow-up period (range 1.5 to 
30 months), this study did not specifically 
examine whether metastatic disease did appear 
at a later time. One mortality was noted in this 
series, in case of large cervical C1-C2 
schwannoma due to respiratory 
complications, and the only complications 
included a superficial wound infection. 
TABLE 2 
Histologic, demographic, and anatomic 
considerations for IDEM spinal cord tumours 
A. Distribution of tumours by histologic type 
and patient gender in this series 
Patient gender Total Men Women 
Schwannoma 113 (56.21%) 69 44 
Meningeoma 68 (33.83%) 14 54 
Ependymoma 20 (9.9%) 10 10 
Total 201 93 108 
B. Tumour incidence by age group 
Age <40 40-60 >60 
Schwannoma 47 47 19 
Meningeoma 4 39 25 
Ependymoma 10 4 6 
Total 61 90 50 
C. Tumour incidence by anatomic location 
Location Cervical Thoracic Lumbar 
Schwannoma 31 38 44 
Meningeoma 19 49 0 
Ependymoma 0 0 20 
Total 50 87 64 
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Figure 1 - T1W MRI sagittal view showing L1-2 
neurofibroma 
 
 
Figure 2 - T2W MRI sagittal view showing L1-2 
neurofibroma 
 
 
Figure 3 - CT abdomen showing left L1-2 
neurofibroma 
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Discussion 
Intradural extramedullary tumors account 
for two-thirds of primary spinal tumors (12). 
Most intradural extramedullary tumors are 
benign, and they exhibit no specific symptoms. 
Radicular pain and worsening sensory and 
motor loss are common manifestations. 
Therefore, most of the patients are wrongly 
diagnosed with cervical spondylopathy or 
intervertebral disk herniation. MRI is very 
crucial to confirm the diagnosis of intradural 
extramedullary tumors. Once the diagnosis is 
confirmed, the best treatment for 
nonmalignant intradural extramedullary 
tumor is surgery. The goal of surgery is 
complete surgical resection while preserving 
spinal stability, without worsening the 
preoperative neurological status. 
All the processes of conventional surgical 
tumor resection are carried out without using 
microscope, which may lead to a greater 
likelihood of incomplete tumor resection, as 
well as more damage to the spinal cord and 
vessels surrounding the spinal canal. With the 
improve ement of medical devices, surgeons are 
increasingly using microscopy to perform 
surgical tumor resection. MIS can provide a 
clearer visual operative field and more delicate 
operative maneuvers, which can avoid the 
damage to the spinal cord and peripheral nerves 
as far as possible, reduce intraoperative blood 
loss and postoperative complications, and 
increase the rate of complete removal of 
tumors. It was reported that MIS allowed 
removal of the tumor with minimal 
impairment from cutting of nerve fibers at the 
nerve root (14). No Poor results were noted in 
this study at the mean 8.5 month follow-up. 
Our findings are similar with those of other 
authors, with majority of clinical improvement 
noted either immediately or within 6 months of 
the operative intervention, with less notable 
clinical change after this initial period (13, 19). 
Other studies reported that duration of 
preoperative symptoms appears to correlate 
with postoperative improvement, and that 
successful complete microsurgical tumor 
excision is of utmost importance (11, 13, 21). In 
terms of mortality, our result correlate well with 
other authors, with a reported range between 0-
4.4% (2, 4, 13). 
Approximately 20% of patients in our 
study had residual focal deficits, none of which 
were disabling. Other authors report similar 
outcome among patients with similarities to 
our patient sample, with significant 
improvement in 62-88% of cases and clinical 
worsening in only a minority of patients (1-
5%) (13).  
The demographics in our study are similar 
to those in previous studies (13, 19). We found 
that schwannomas affected younger male 
patients, meningiomas tended to occur in 
women and older patients. Patients with 
myxopapillary ependymomas were younger 
than patients with schwannomas.   
The reported frequencies of schwannomas 
among IDEM spinal cord tumours vary from 
43% to 67% in other studies as copared to 
56.21% in our series (7, 10, 13, 19). 
Schwannomas tend to produce localized pain, 
radiculopathy, and cauda equina syndrome. 
Most report schwannomas to be solitary, with 
a 2.5% malignancy rate, which carries a poor 
prognosis (8). In our study, schwannomas 
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were the only group of tumors without a 
predominant location of occurrence, and 
constituted 75% of recurrent tumors.  
In this study, patients with meningiomas 
were older than those with other tumor types. 
Findings in this series agree with the literature 
in that meningiomas are the second most 
common IDEM, with approximately 80% 
localized to the thoracic region (72.05% in this 
study) (8, 9, 11). Between 75% and 85% of 
patients with meningiomas are women 
(79.41% in this study), who tend to be older 
than patients with schwannomas or 
ependymomas (8, 11, 19). Consistent with 
previous reports, we found meningiomas to be 
more aggressive in younger patients, with the 
higher incidence of myelopathy likely due to 
predilection of meningiomas for the thoracic 
region (5). Others describe higher operative 
morbidity associated with IDEM spinal cord 
tumours located in the thoracic region 19. 
Meningiomas tend to produce the “dural tail” 
sign on MRI scans in sagittal, axial, and 
coronal planes, and it is recommended that all 
three planes of visualization be used 20. We 
follow this recommendation because as many 
as 10% of meningiomas can be both intradural 
and extradural (12).  
Myxopapillary ependymomas constitute 
9.9 % of IDEM spinal cord tumours in this 
study, and although in this study 
ependymomas had equal distribution among 
men and women, another series reported twice 
as many men as women (24). In this study, the 
mean age of the ependymoma group was lower 
than the mean age of patients with 
meningioma or schwannoma. 
Symptomatically, ependymomas tended to 
produce cauda equina syndrome, localized 
pain, and radiculopathy.  
A 4:2:1 ratio of schwannomas to 
meningiomas to ependymomas was observed in 
this series. Although not specifically described by 
others, similar ratio of tumor types can be noted 
in previous reports (10, 13, 19). 
Limitations of this study include its 
retrospective nature, lack of patient follow up 
data beyond the 8.5-month mean follow up 
period, lack of complete data on recurrences or 
metastases beyond the end of the study period, 
and the drawbacks of the Odom's modified 
criteria as a measurement tool for morbidity. The 
Odom's modified scale is a very ‘rough' 
instrument of outcome assessment and does not 
have the capacity to truly delineate actual 
morbidity. The Odom's scale was chosen for this 
study because of standard and uniform reporting 
of this scale on our patient charts. Although the 
use of scales such as SF-36 or Nurick grading 
would greatly enhance this study, the long period 
of this study as well as the difficulty of assigning 
these scales in a retrospective fashion to every 
patient in this study, make their applicability 
impractical (3, 15).  
Conclusions 
Surgery for IDEM spinal cord tumours, with 
goal of complete tumor removal, is a safe and 
effective option. At the 8.5 month mean follow-
up, majority of patients had complete or near 
complete relief of symptoms and return to full 
activity Schwannomas and ependymomas were 
the only histologic types to recur. Demographic, 
tumor-specific and anatomic considerations 
may be clinically useful when approaching 
IDEM spinal cord tumours. 
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